Vitamin K-dependent clotting factors, combined deficiency of, type 1
MONDO:0010187Combined vitamin K-dependent clotting factors deficiency (VKCFD) is a congenital bleeding disorder resulting from variably decreased levels of coagulation factors II, VII, IX and X, as well as natural anticoagulants protein C, protein S and protein Z.
Also known as: GGCX congenital vitamin K-dependent coagulation factors combined deficiency, congenital vitamin K-dependent coagulation factors combined deficiency caused by mutation in GGCX, hereditary combined deficiency of factors II, VII, IX and X, vitamin K-dependent clotting factors, combined deficiency of, type 1, FMFD 3, VKCFD1, Vkcfd, factors II, VII, IX, and X, combined deficiency of
13 clinical trials for this condition and its sub-types, 1 tagged with Vitamin K-dependent clotting factors, combined deficiency of, type 1 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Head-to-Head safety check: which Clot-Reversal drug is safer before emergency surgery?
Disease control OngoingThis observational study compares the safety of two drugs, BALFAXAR and KCENTRA, used to reverse the effects of vitamin K antagonist blood thinners (like warfarin) in adults who need urgent surgery or an invasive procedure. The main goal is to see how often blood clots (thromboem…
Sponsor: Octapharma • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
AI takes on blood clotting: can ChatGPT guide surgeons on bleeding?
Knowledge-focused CancelledThis study evaluates whether artificial intelligence models can accurately interpret ROTEM blood clotting tests and recommend treatments for coagulopathy. Researchers will compare AI decisions to those of a panel of clinical experts using data from adults undergoing elective card…
Sponsor: Ondokuz Mayıs University • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC